REFERENCES
- Darrell RW, Wagener HP, Kurland LT. Epidemiology of uveitis. Incidence and prevalence in a small urban community. Arch Ophthalmol. 1962;68:502–514.
- Nussenblatt RB. The natural history of uveitis. Int Ophthalmol. 1990;14:303–308.
- Dandona L, Dandona R, John RK, et al. Population based assessment of uveitis in an urban population in southern India. Br J Ophthalmol. 2000;84:706–709.
- Tran VT, Auer C, Guex-Crosier Y, et al. Epidemiology of uveitis in Switzerland. Ocul Immunol Inflamm. 1994;2:169–176.
- Glasner PD, Silveira C, Kruszon-Moran D, et al. An unusually high prevalence of ocular toxoplasmosis in southern Brazil. Am J Ophthalmol. 1992;114:136–144.
- Rathinam SR, Namperumalsamy P. Global variation and pattern changes in epidemiology of uveitis. Indian J Ophthalmol. 2007;55:173–183.
- Kitamei H, Kitaichi N, Namba K, et al. Clinical features of intraocular inflammation in Hokkaido, Japan. Acta Ophthalmol. 2009;87:424–428.
- Kase S, Namba K, Kitaichi N, et al. Clinical features of human T lymphotropic virus type 1-associated uveitis in Hokkaido, Japan. Jpn J Ophthalmol. 2013;57:379–384.
- Sugiura S. [Some observations on uveitis in Japan, with special reference to Vogt–Koyanagi–Harada and Behçet diseases.] Nippon Ganka Gakkai Zasshi. 1976;80:1285–1326.
- Furudate N, Kotake S, Sasamoto Y, et al. [Incidence of uveitis at Hokkaido University Hospital.] Rinsho Ganka. 1993;47:1237–1241.
- Ohguro N, Sonoda KH, Takeuchi M, et al. The 2009 prospective multi-center epidemiologic survey of uveitis in Japan. Jpn J Ophthalmol. 2012;56:432–435.
- Imai R, Uegaki N. [Statistical analysis of iridocyclitis at Izumibashi Charity Hospital for 2 years.] Nippon Ganka Gakkai Zasshi. 1934;41:460–470.
- Aoki K. [Pictures of uveitis in Hokkaido.] Ganka Rinsho Iho. 1970;64:22–24.
- Goto H, Mochizuki M, Yamaki K, et al. Epidemiological survey of intraocular inflammation in Japan. Jpn J Ophthalmol. 2007;51:41–44.
- Yoshida A, Kawashima H, Motoyama Y, et al. Comparison of patients with Behçet’s disease in the 1980s and 1990s. Ophthalmology. 2004;111:810–815.
- Ohno S, Aoki A, Sugiura S, et al. HL-A5 and Behçet’s disease. Lancet. 1973;2:1383–1384.
- Horie Y, Meguro A, Ohta T, et al. HLA-B51 carriers are susceptible to ocular symptoms of Behcet disease and the association between the two becomes stronger towards the East along Silk Road: a literature survey. Ocul Immunol Inflamm. 2016. 10.3109/09273948.2015.1136422 [Epub ahead of print]
- Consolandi C, Turroni S, Emmi G, et al. Behçet’s syndrome patients exhibit specific microbiome signature. Autoimmun Rev. 2015;14:269–276.
- Oh SH, Lee KY, Lee JH, et al. Clinical manifestations associated with high titer of anti-streptolysin O in Behcet’s disease. Clin Rheumatol. 2008;27:999–1003.
- Kotake S, Furudate N, Sasamoto Y, et al. Characteristics of endogenous uveitis in Hokkaido, Japan. Graefes Arch Clin Exp Ophthalmol. 1996;234:599–603.
- Yamaguchi A, Tsuchiya N, Mitsui H, et al. Association of HLA-B39 with HLA-B27-negative ankylosing spondylitis and pauciarticular juvenile rheumatoid arthritis in Japanese patients. Evidence for a role of the peptide-anchoring B pocket. Arthritis Rheum. 1995;38:1672–1677.
- Goto K, Saeki K, Kurita M, et al. HTLV-I associated uveitis in central Japan. Br J Ophthalmol. 1995;79:1018–1020.
- Nakao K, Ohba N, Matsumoto M. Noninfectious anterior uveitis in patients infected with human T-lymphotropic virus type I. Jpn J Ophthalmol. 1989;33:472–481.
- Shimouchi A, Ohkado A, Matsumoto K, et al. Strengthened tuberculosis control programme and trend of multi-drug resistant tuberculosis rate in Osaka City, Japan. Western Pac Surveill Response J. 2013;4:4–10.
- Keino H, Nakashima C, Watanabe T, et al. Frequency and clinical features of intraocular inflammation in Tokyo. Clin Experiment Ophthalmol. 2009;37:595–601.
- Sugita S, Ogawa M, Shimizu N, et al. Use of a comprehensive polymerase chain reaction system for diagnosis of ocular infectious diseases. Ophthalmology. 2013;120:1761–1768.